Researchers dig into Real-World cancer drug data

NCT ID NCT07223372

Not yet recruiting Knowledge-focused Sponsor: Bayer Source: ClinicalTrials.gov ↗

Summary

This study looks back at prescription records to understand how Australian men with advanced prostate cancer are being treated. Researchers will analyze existing pharmacy data from about 1,000 patients who received newer hormone therapy drugs. The goal is to learn about treatment patterns, patient characteristics, and medication adherence in real-world settings.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC HORMONESENSITIVE PROSTATE CANCER (MHSPC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.